Anticoagulant prescribing in patients with ischaemic stroke: what has changed over a decade? | Zendy

Sharobeam Angelos | Zendy; Jones Brett | Zendy; Watters Aidan | Zendy; Das Chandi | Zendy; Lueck Christian | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Anticoagulant prescribing in patients with ischaemic stroke: what has changed over a decade?

Author(s) -

Sharobeam Angelos,

Jones Brett,

Watters Aidan,

Das Chandi,

Lueck Christian

Publication year - 2020

Publication title -

internal medicine journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.596

H-Index - 70

eISSN - 1445-5994

pISSN - 1444-0903

DOI - 10.1111/imj.15022

Subject(s) - medicine , atrial fibrillation , warfarin , anticoagulant , ischaemic stroke , stroke (engine) , oral anticoagulant , cardiology , mechanical engineering , engineering

A study at our institution conducted 10 years ago identified that warfarin was under‐utilised in patients with atrial fibrillation. We replicated this study and compared the results. There was a significant increase in the proportion of patients appropriately anticoagulated (63% vs 9%, P < 0.001). Eighty‐seven percent of eligible patients were appropriately anticoagulated on discharge (86% previously). Seventy‐two percent of treated patients were prescribed a direct oral anticoagulant. Of these, 10% were discharged with a sub‐therapeutic dose without obvious explanation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research